Cervical cancer trials in India
8 of 17 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleImpact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India
- Where
- Gangtok
- Age
- 18 years to 22 years
- People
- 5,500
- Run by
- International Agency for Research on Cancer
See details and how to joinNCT04588402 - No phaseTaking peopleLate Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
- Where
- Mumbai
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Tata Memorial Hospital
See details and how to joinNCT07435623 - No phaseTaking peopleDevelopment of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
- Where
- Navi Mumbai
- Age
- 18 years to 90 years
- People
- 1,800
- Run by
- Tata Memorial Hospital
See details and how to joinNCT05102240 - No phaseTaking peopleCervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
- Where
- Mumbai
- People
- 350
- Run by
- Tata Memorial Hospital
See details and how to joinNCT07400809 - No phaseTaking peopleAsian Gynecological Brachytherapy Registry in Cervical Cancer
- Where
- Mumbai
- People
- 1,000 worldwide
- Run by
- Tata Memorial Hospital
See details and how to joinNCT07196033 - No phaseTaking peopleSystemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer
- Where
- Mumbai
- Age
- 18 years and over
- People
- 110
- Run by
- Tata Memorial Hospital
See details and how to joinNCT06804135 - No phaseTaking peopleCompliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India
- Where
- Mumbai
- People
- 618
- Run by
- Tata Memorial Hospital
See details and how to joinNCT07290972 - No phaseNot yet taking people in IndiaThis is a Multicentre International Study Evaluating CT-based IGABT With / Without Either TRUS During BT/Pre BT MR as Per IBS-GECESTRO-ABS Recommendations for Target contouring-as an Alternative to MRIGABT for Cervical Cancer From Implementation Perspectives Under EMBRACE-III:TRIPLET IMPACT Study.
- Where
- Visakhapatnam
- Age
- 18 years and over
- People
- 1,200
- Run by
- Homi Bhabha Cancer Hospital & Research Centre
See details and how to joinNCT07249021